Filing Details
Ocugen, Inc. (NASDAQ:OCGN) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedNASDAQ:OCGN
Ocugen, Inc. (OCGN) Reports Material Event to SEC
Filing Details Ocugen, Inc. (NASDAQ:OCGN) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market Context Ocugen, Inc.'s…
Market Context
Ocugen, Inc.'s stock currently trades at $1.41 with a market capitalization of $409.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Ocugen, Inc.'s stock.
All SEC filings for Ocugen, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OCGN Stock Page
Frequently Asked Questions
Where can I read OCGN's SEC filings?
Browse all filings on our OCGN SEC filings page.
What types of SEC filings does Ocugen, Inc. file?
Public companies like Ocugen, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.